Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maximilian Burger

Showing results (281-290 of 342) with videos related to

Pageof 35
Sort By:
World Journal of Urology|December 1, 2021
Impact of COVID-19 crisis on medical care of patients with metastasized uro-oncologic disease under systemic cancer therapy: a multicenter study in German university hospitalsJulian P Struck, Maike Schnoor, Andrea Schulze, et al.
BJU International|January 12, 2013
Ki-67, mini-chromosome maintenance 2 protein (MCM2) and geminin have no independent prognostic relevance for cancer-specific survival in surgically treated squamous cell carcinoma of the penisMatthias May, Maximilian Burger, Wolfgang Otto, et al.
European Urology|June 29, 2020
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 UpdateMorgan Rouprêt, Marko Babjuk, Maximilian Burger, et al.
Journal of Cancer|March 7, 2017
Immunohistochemical and molecular characterizations in urothelial carcinoma of bladder in patients less than 45 yearsVeronika Weyerer, Roland Schneckenpointner, Thomas Filbeck, et al.
Journal for Immunotherapy of Cancer|May 26, 2020
Cytotoxic T-cell-related gene expression signature predicts improved survival in muscle-invasive urothelial bladder cancer patients after radical cystectomy and adjuvant chemotherapyMarkus Eckstein, Pamela Strissel, Reiner Strick, et al.
European Urology|March 21, 2020
Transurethral Resection of Bladder Tumour: The Neglected Procedure in the Technology Race in Bladder CancerHugh Mostafid, Marko Babjuk, Bernard Bochner, et al.
European Journal of Cancer (Oxford, England : 1990)|December 12, 2018
Performance of the Food and Drug Administration/EMA-approved programmed cell death ligand-1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumabMarkus Eckstein, Philipp Erben, Maximilian C Kriegmair, et al.
The Journal of Urology|February 17, 2012
External validation of a risk model to predict recurrence-free survival after radical cystectomy in patients with pathological tumor stage T3N0 urothelial carcinoma of the bladderMatthias May, Patrick J Bastian, Sabine Brookman-May, et al.
European Urology Focus|November 22, 2017
Potential Benefit of Lymph Node Dissection During Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the European Association of Urology Guidelines Panel on Non-muscle-invasive Bladder CancerJose Luis Dominguez-Escrig, Benoit Peyronnet, Thomas Seisen, et al.
BJU International|June 26, 2012
Obesity is associated with worse oncological outcomes in patients treated with radical cystectomyThomas F Chromecki, Eugene K Cha, Harun Fajkovic, et al.
Pageof 35

Showing results (281-290 of 342) with videos related to

Sort By:
Pageof 35
World Journal of Urology|December 1, 2021
Impact of COVID-19 crisis on medical care of patients with metastasized uro-oncologic disease under systemic cancer therapy: a multicenter study in German university hospitalsJulian P Struck, Maike Schnoor, Andrea Schulze, et al.
BJU International|January 12, 2013
Ki-67, mini-chromosome maintenance 2 protein (MCM2) and geminin have no independent prognostic relevance for cancer-specific survival in surgically treated squamous cell carcinoma of the penisMatthias May, Maximilian Burger, Wolfgang Otto, et al.
European Urology|June 29, 2020
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 UpdateMorgan Rouprêt, Marko Babjuk, Maximilian Burger, et al.
Journal of Cancer|March 7, 2017
Immunohistochemical and molecular characterizations in urothelial carcinoma of bladder in patients less than 45 yearsVeronika Weyerer, Roland Schneckenpointner, Thomas Filbeck, et al.
Journal for Immunotherapy of Cancer|May 26, 2020
Cytotoxic T-cell-related gene expression signature predicts improved survival in muscle-invasive urothelial bladder cancer patients after radical cystectomy and adjuvant chemotherapyMarkus Eckstein, Pamela Strissel, Reiner Strick, et al.
European Urology|March 21, 2020
Transurethral Resection of Bladder Tumour: The Neglected Procedure in the Technology Race in Bladder CancerHugh Mostafid, Marko Babjuk, Bernard Bochner, et al.
European Journal of Cancer (Oxford, England : 1990)|December 12, 2018
Performance of the Food and Drug Administration/EMA-approved programmed cell death ligand-1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumabMarkus Eckstein, Philipp Erben, Maximilian C Kriegmair, et al.
The Journal of Urology|February 17, 2012
External validation of a risk model to predict recurrence-free survival after radical cystectomy in patients with pathological tumor stage T3N0 urothelial carcinoma of the bladderMatthias May, Patrick J Bastian, Sabine Brookman-May, et al.
European Urology Focus|November 22, 2017
Potential Benefit of Lymph Node Dissection During Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the European Association of Urology Guidelines Panel on Non-muscle-invasive Bladder CancerJose Luis Dominguez-Escrig, Benoit Peyronnet, Thomas Seisen, et al.
BJU International|June 26, 2012
Obesity is associated with worse oncological outcomes in patients treated with radical cystectomyThomas F Chromecki, Eugene K Cha, Harun Fajkovic, et al.
Pageof 35